Cargando…
Re: Musings on malaria morbidity and mortality after the new Mosquirix(®) vaccine
Autores principales: | Asante, Kwaku Poku, Malm, Keziah, Darko, Delise Mimi, Koram, Kwadwo Ansah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ghana Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842733/ https://www.ncbi.nlm.nih.gov/pubmed/31741498 http://dx.doi.org/10.4314/gmj.v53i3.10 |
Ejemplares similares
-
Musings on malaria morbidity and mortality after the new Mosquirix(®) vaccine
por: Sackey, Adziri H
Publicado: (2019) -
Malaria vaccine deployment in Africa: focus on Ghana
por: Asante, Kwaku Poku, et al.
Publicado: (2019) -
RTS,S/AS01 malaria vaccine (Mosquirix(®)): a profile of its use
por: Syed, Yahiya Y.
Publicado: (2022) -
Probing the composition of Plasmodium species contained in malaria infections in the Eastern region of Ghana
por: Amoah, Linda Eva, et al.
Publicado: (2019) -
Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
por: Nadeem, Aroosa Younis, et al.
Publicado: (2022)